Print（PDF/132KB） Jul. 18, 2025 Corporate

Sumitomo Pharma Announces Changes in the Position Assumed by Executive Officer and Other Key Positions

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Toru Kimura) today announced the following changes in the position assumed by Executive Officer and other key positions, effective August 1, 2025.

I. Change in the Position Assumed by Executive Officer (effective August 1, 2025)

Position as of August 1, 2025	Current position	Name
Executive Officer Global Corporate Strategy Global Finance	Executive Officer Global Corporate Strategy Global Finance Vice President, Head of Global Corporate Strategy	Yutaka Wakemi

II. Changes in Personnel (effective August 1, 2025)

Corporate Department

Position as of August 1, 2025	Current position	Name
Vice President, Head of Global Corporate Strategy	Vice President, Head of R&D Strategy and Planning	Masakuni Horiguchi
Senior officer, Regenerative & Cellular Medicine Business RACTHERA Co., Ltd. Regenerative & Cellular Medicine Office	Senior officer, Regenerative & Cellular Medicine Business RACTHERA Co., Ltd.	Makoto Inoue

Research and Development (Division)

Position as of August 1, 2025	Current position	Name
Vice President, Head of R&D Strategy and Planning	Vice President, Head of Cancer Drug Discovery Research Unit	Hitoshi Ban
Vice President, Head of Cancer Drug Discovery Research Unit Senior Director, Modality Research Group I, Cancer Drug Discovery Research Unit	Senior Director, Modality Research Group I, Cancer Drug Discovery Research Unit	Seiji Kamioka